2146 Results

People

  1. Aghajanian
    Aghajanian
  2. Hensley
    Hensley
  3. Abu-Rustum
    Abu-Rustum
  4. O'Cearbhaill
    O'Cearbhaill
  5. Makker
    Makker
  6. Tew
    Tew
  7. Lichtman
    Lichtman
  8. Zamarin
    Zamarin
  9. Chi
    Chi
  10. Iasonos
    Iasonos

Groups

  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)
  7. GDMT, Surgery (474)
  8. Epidemiology and Biostatistics (398)
  9. Department of Pathology and Laboratory Medicine (395)
  10. Survivorship Research (390)
  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk stratification of stage I grade 3 endometrioid endometrial carcinoma
    Meeting Abstract

    Zammarrelli, W.; Kim, S.; Paula, A. D. C.; Rios-Doria, E.; Zhou, Q.; Alektiar, K.; Aghajanian, C.; Makker, V.; Leitao, M.; Abu-Rustum, N.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer with high folate receptor alpha expression: Results from the SORAYA study
    Meeting Abstract

    Matulonis, U.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. R.; Harter, P.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Long term survival of GOG 252 'randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/GOG study'
    Meeting Abstract

    Walker, J.; Mark, B.; Moore, K.; Tewari, K.; Thaker, P.; DiSilvestro, P.; Van Le, L.; Guntupalli, S.; Gray, H.; Rose, P.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma
    Journal Article

    O'Malley, D. M.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer
    Review

    Rubinstein, M.; Shen, S.; Monk, B. J.; Tan, D. S. P.; Nogueira-Rodrigues, A.; Aoki, D.; Sehouli, J.; Makker, V.
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy of niraparib by timing of surgery and residual disease: A post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
    Meeting Abstract

    O'Cearbhaill, R.; Grabowski, J.; Pérez-Fidalgo, J. A.; Monk, B. J.; Tusquets, I.; Mccormick, C.; Pradera, J. F.; Moore, R. G.; Vulsteke, C.; Shahin, M.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial
    Meeting Abstract

    Hollebecque, A.; Borad, M.; Goyal, L.; Schram, A.; Park, J. O.; Cassier, P. A.; Kamath, S. D.; Meng, D. T. W.; Dotan, E.; Kim, R.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Personalized, off-the-shelf KRAS neoantigen-specific immunotherapy for the treatment of advanced solid tumors: Clinical benefit associated with decreases in ctDNA (SLATE-KRAS)
    Meeting Abstract

    Kyi, C. K.; Spira, A.; Carbone, D. P.; Johnson, M. L.; Henick, B. S.; Johnson, B.; Borghaei, H.; Mahipal, A.; Hecht, J. R.; Catenacci, D.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Anti-cytotoxic T-lymphocyte antigen-4 (CTLA 4) probody BMS-986249 ± nivolumab (NIVO) in patients (pts) with advanced cancers: Updated phase I results
    Meeting Abstract

    Gutierrez, M.; Friedman, C. F.; Long, G. V.; Ascierto, P. A.; Melero, I.; Richards, D.; Bastos, B. R.; Moreno Garcia, V.; Uemura, M.; Conkling, P.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor a (FR a)-positive cancer
    Meeting Abstract

    Matulonis, U. A.; Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Romeo Marin, M.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save